CINECA IRIS Institutional Research Information System

CRISAFULLI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.201
EU - Europa 2.793
AS - Asia 2.124
OC - Oceania 65
SA - Sud America 41
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.245
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.105
IT - Italia 1.240
CN - Cina 1.235
GB - Regno Unito 259
DE - Germania 234
JP - Giappone 212
FR - Francia 209
SG - Singapore 176
IE - Irlanda 124
SE - Svezia 123
HK - Hong Kong 108
ES - Italia 96
IN - India 86
CA - Canada 74
FI - Finlandia 73
KR - Corea 63
TW - Taiwan 55
ID - Indonesia 53
NL - Olanda 50
BE - Belgio 46
AU - Australia 44
PL - Polonia 43
UA - Ucraina 41
AT - Austria 38
DK - Danimarca 31
GR - Grecia 28
IL - Israele 28
CH - Svizzera 27
VN - Vietnam 23
BR - Brasile 21
NZ - Nuova Zelanda 21
HU - Ungheria 20
MX - Messico 20
NO - Norvegia 20
CZ - Repubblica Ceca 19
PT - Portogallo 17
TR - Turchia 15
RO - Romania 14
RU - Federazione Russa 12
AR - Argentina 11
IR - Iran 11
TH - Thailandia 11
BA - Bosnia-Erzegovina 10
MY - Malesia 10
AM - Armenia 8
HR - Croazia 6
EG - Egitto 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
BN - Brunei Darussalam 4
KZ - Kazakistan 4
RS - Serbia 4
CL - Cile 3
CO - Colombia 3
CY - Cipro 3
PK - Pakistan 3
SA - Arabia Saudita 3
AP - ???statistics.table.value.countryCode.AP??? 2
DZ - Algeria 2
EU - Europa 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
LT - Lituania 2
LU - Lussemburgo 2
PE - Perù 2
SN - Senegal 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
HN - Honduras 1
LK - Sri Lanka 1
PR - Porto Rico 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 8.245
Salva come PNG Salva come JPEG
Città #
Ann Arbor 427
Chandler 275
Beijing 213
Shanghai 176
Redwood City 146
Houston 128
Guangzhou 127
Singapore 127
Milan 126
Torino 126
Fairfield 121
Dublin 114
Turin 106
Ashburn 94
Cambridge 88
Woodbridge 79
Seattle 78
New York 75
Tokyo 66
Wilmington 66
Dearborn 61
Nanjing 55
Rome 48
Boston 47
Jakarta 47
Nyköping 46
Hangzhou 42
Wuhan 41
Lappeenranta 40
Pisa 36
Villeurbanne 34
Vienna 33
London 31
Carrara 29
Genoa 29
Los Angeles 27
Medford 27
Paris 26
Brussels 25
Taipei 25
Barcelona 24
Munich 24
San Diego 24
Berlin 23
Boardman 23
Central 23
Princeton 23
Jacksonville 22
Central District 20
Fremont 20
Warsaw 20
Luni 19
Bologna 18
Chongqing 18
San Francisco 18
Jinan 17
Chicago 16
Duncan 16
Santa Clara 16
Shenyang 16
Toulouse 16
Buffalo 15
Changsha 15
Helsinki 15
Ottawa 15
Redmond 15
San Mateo 15
Tianjin 15
Toronto 15
Chengdu 14
Norwalk 14
Rochester 14
Pittsburgh 13
Xian 13
Dallas 12
Hong Kong 12
Phoenix 12
Seoul 12
Melbourne 11
Somerville 11
Washington 11
Budapest 10
Dong Ket 10
Grafing 10
Lyngby 10
New Haven 10
Rehovot 10
Shenzhen 10
Zhengzhou 10
Baltimore 9
Birmingham 9
Dunedin 9
Fuzhou 9
Madrid 9
Mainz 9
Nanchang 9
Oslo 9
Palermo 9
Silver Spring 9
Simi Valley 9
Totale 4.371
Salva come PNG Salva come JPEG
Nome #
Inactivation of DNA repair triggers neoantigen generation and impairs tumour growth 1.816
Adaptive mutability of colorectal cancers in response to targeted therapies 1.716
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor 692
A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology 562
Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer 441
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients 368
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer 287
Genetic Evolution of Glioblastoma Stem-Like Cells From Primary to Recurrent Tumor 237
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions 236
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients 217
Molecular landscape of acquired resistance to targeted therapy combinations in BRAF mutant colorectal cancer 194
Acquired resistance to the TRK inhibitor entrectinib in colorectal cancer 184
Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases 176
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 161
Tracking colorectal cancer evolution in time and space 151
Radiologic and Genomic Evolution of Individual Metastases during HER2 Blockade in Colorectal Cancer 145
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination 86
Werner helicase is a synthetic-lethal vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy and Immunotherapy 84
Tumor heterogeneity and Lesion-Specific response to targeted therapy in colorectal cancer 77
Temozolomide drives mismatch repair deficiency and fosters neoantigen generation in tumor cells 64
Graves' disease prevalence in a young population with Turner syndrome 61
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial 58
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer 58
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study 53
A modified fluctuation-test framework characterizes the population dynamics and mutation rate of colorectal cancer persister cells 44
Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients 43
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas 40
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient 19
Liquid biopsy of cerebrospinal fluid enables selective profiling of glioma molecular subtypes at first clinical presentation 14
Transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer 14
Abstract A120: Adaptive mutability of colorectal cancers in response to targeted therapies 14
Abstract LB058: A transcriptome-wide gene expression outlier analysis pinpoints therapeutic vulnerabilities in colorectal cancer 12
Abstract 6262: Emergence of tumor mismatch repair deficiency and increased mutational burden in blood and tissue of metastatic colorectal cancer patients treated with temozolomide 9
Abstract 2913: Emergence of RAS or EGFR mutant clones affects duration of response to EGFR blockade in colorectal cancers 9
Abstract 6402: The effects of cytotoxic chemotherapy on colorectal cancer immunogenicity 8
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer 8
Abstract 2613: A modified Luria-Delbrück assay allows quantification of colorectal cancer persister cells’ mutation rate 7
Abstract 5284: Immune surveillance of chemotherapy-induced mutant subclones in CRC 7
Mutational Signatures in Colorectal Cancer: Translational Insights, Clinical Applications, and Limitations 7
Abstract A001: Reshaping the immune microenvironment after temozolomide priming in metastatic colorectal cancer patients in ARETHUSA clinical trial 6
Abstract 3834: Tracking CAD-ALK gene translocation in urine and plasma of a colorectal cancer patient treated with ALK blockade 6
Abstract 5723: Inactivation of DNA repair triggers neoantigen generation and impairs tumor growth 6
Abstract B11: Whole-exome sequencing analysis of urine transrenal tumor DNA in metastatic colorectal cancer patients 6
Abstract 2743: Accumulation of predicted neoantigens by MMR deficiency triggered by temozolomide treatment of human colorectal cancer 6
Abstract 616: Blood-based molecular landscapes of resistance to EGFR blockade in colorectal cancer patients 6
Abstract 3588: Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer 6
Abstract 2848: Radiographic and genomic evolution of individual metastases during HER2 blockade in colorectal cancer 6
Pembrolizumab in MMR-proficient metastatic colorectal cancer pharmacologically primed to trigger dynamic hypermutation status: The ARETHUSA trial 5
Assessment of HER2 (ERBB2) amplification (HER2amp) using blood-based circulating tumor DNA (ctDNA) next generation sequencing (NGS) and correlation with tissue-based testing in metastatic colorectal cancer (mCRC) 5
Abstract 878: Tumor heterogeneity and lesion-specific response to targeted therapy in colorectal cancer 5
Raise and decline of KRAS mutant clones in colorectal cancers (CRCs) treated with multiple rounds of anti-EGFR antibodies 4
Editorial: The impact of genetics on CRC therapy: from adaptive mutability to drug resistance 4
An extended multi-locus molecular typing schema for Streptococcus pneumoniae demonstrates that a limited number of capsular switch events is responsible for serotype heterogeneity of closely related strains from different countries 4
Sequence Analysis of 96 Genomic Regions Identifies Distinct Evolutionary Lineages within CC156, the Largest Streptococcus pneumoniae Clonal Complex in the MLST Database 3
Mutational signatures of colorectal cancers according to distinct computational workflows 3
Abstract 3588: Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer 2
Totale 8.462
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.728
article - articoli 0
book - libri 0
conference - conferenze 762
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.490
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020673 0 0 40 68 51 67 59 61 98 103 84 42
2020/20211.420 50 69 81 141 134 120 145 94 126 164 131 165
2021/20221.686 184 167 155 221 85 102 120 112 124 99 178 139
2022/20231.650 109 122 123 155 121 196 122 164 181 89 147 121
2023/20241.449 118 132 126 110 110 134 134 110 38 143 143 151
2024/2025423 76 104 243 0 0 0 0 0 0 0 0 0
Totale 8.462